| Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in … RR Bahadoer, EA Dijkstra, B van Etten, CAM Marijnen, H Putter, ... The Lancet Oncology 22 (1), 29-42, 2021 | 1745 | 2021 |
| Digitoxin is a potential anticancer agent for several types of cancer J Haux Medical hypotheses 53 (6), 543-548, 1999 | 234 | 1999 |
| Digitoxin medication and cancer; case control and internal dose-response studies J Haux, O Klepp, O Spigset, S Tretli BMC cancer 1 (1), 11, 2001 | 194 | 2001 |
| Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial KJ Labori, SO Bratlie, B Andersson, JH Angelsen, C Biörserud, ... The Lancet Gastroenterology & Hepatology 9 (3), 205-217, 2024 | 188 | 2024 |
| Regulation of APO-2 ligand/trail expression in NK cells—involvement in NK cell-mediated cytotoxicity AC Johnsen, J Haux, B Steinkjer, U Nonstad, K Egeberg, A Sundan, ... Cytokine 11 (9), 664-672, 1999 | 140 | 1999 |
| Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity AE Medvedev, AC Johnsen, J Haux, B Steinkjer, K Egeberg, DH Lynch, ... Cytokine 9 (6), 394-404, 1997 | 123 | 1997 |
| Short-course neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer: A multicenter randomized phase-II trial (NORPACT-1). KJ Labori, SO Bratlie, C Biörserud, B Björnsson, E Bringeland, N Elander, ... Journal of clinical oncology 41 (17_suppl), LBA4005-LBA4005, 2023 | 50 | 2023 |
| Digitoxin, in non toxic concentrations, induces apoptotic cell death in Jurkat T cells in vitro J Haux, M Lain, ABL Marthinsen, T Strickert, S Lundgren ZEITSCHRIFT FUR ONKOLOGIE 31, 14-14, 1999 | 48 | 1999 |
| Digitoxin, in non-toxic concentrations, inhibits proliferation and induces cell death in prostate cancer cell lines J Haux, O Solheim, T Isaksen, A Angelsen Zeitschrift für Onkologie 32 (01), 11-16, 2000 | 36 | 2000 |
| The role of interleukin-2 in regulating the sensitivity of natural killer cells for Fas-mediated apoptosis J Haux, AC Johnsen, B Steinkjer, K Egeberg, A Sundan, T Espevik Cancer Immunology, Immunotherapy 48 (2), 139-146, 1999 | 27 | 1999 |
| SOULMATE: the Swedish study of liver transplantation for isolated colorectal cancer liver metastases not suitable for operation or ablation, compared to best established … V Reivell, H Hagman, J Haux, C Jorns, P Lindner, H Taflin Trials 23 (1), 831, 2022 | 22 | 2022 |
| Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide … B Glimelius, T Khan, K Adolfsson, E Angenete, Å Berglund, K Bonde, ... EClinicalMedicine 75, 2024 | 17 | 2024 |
| The dynamics of cell proliferation JF Moxnes, J Haux, K Hausken Medical hypotheses 62 (4), 556-563, 2004 | 16 | 2004 |
| Digitalis; impinges on more than just the (ion-) pump J Haux Medical hypotheses 59 (6), 781-782, 2002 | 16 | 2002 |
| Infection and cancer J Haux The Lancet 358 (9276), 155-156, 2001 | 13 | 2001 |
| Digitoxin sensitizes malignant breast cancer cells for radiation in vitro J Haux, ABL Marthinsen, M Gulbrandsen, AS Alfredsen, H Johansen, ... ZEITSCHRIFT FUR ONKOLOGIE 31, 61-65, 1999 | 11 | 1999 |
| Digitoxin has specific properties for potential use to treat cancer and inflammatory diseases J Haux Research and Reviews on Healthcare: Open Access Journal 2, 2018 | 9 | 2018 |
| A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer G Carlsson, A Koumarianou, TK Guren, J Haux, P Katsaounis, ... ESMO open 7 (5), 100589, 2022 | 2 | 2022 |
| ISO-005; An open-label, multiple-site, dose cohort, phase I/II study in patients with stage IV colorectal cancer. HA Taflin, Y Wettergren, E Odin, J Haux, B Gustavsson, GU Carlsson Journal of Clinical Oncology 35 (4_suppl), TPS811-TPS811, 2017 | 2 | 2017 |
| Promoting large multinational academic clinical trials for gastrointestinal cancers in Europe: the ENGIC (European Network for GI Cancers) initiative J Taieb, J Seligmann, D Modest, C Girault, F Rivera, E Mahillo, ... ESMO open 10 (5), 105055, 2025 | 1 | 2025 |
